Earnings call transcript: Xenia Hotels Q1 2026 beats forecasts, stock slips

Xenia Hotels & Resorts posted a strong Q1 2026 beat, with EPS of $0.21 versus $0.17 consensus and revenue of $295.41 million versus $288.4 million, while same-property RevPAR rose 7.4% and adjusted EBITDA increased 11.8% year over year. Management raised full-year 2026 Adjusted EBITDAre guidance by $6 million to a $266 million midpoint and AFFO per share guidance to $1.94, though the stock slipped 1.23% pre-market to $16.07. The company also highlighted record performance at Grand Hyatt Scottsdale and solid liquidity, supporting a constructive outlook despite some event-related and weather-related headwinds.

Analysis

XHR’s print is less about a clean beat and more about a quality-of-earnings re-rating: the mix shifted toward higher-margin rate and ancillary spend, which matters more than headline RevPAR in a normalized supply world. That makes the stock’s pre-market dip look like a mechanical “sell the good news” reaction rather than a thesis break; the real signal is that management is now converting occupancy recovery into margin expansion, which should persist if wage inflation stays contained.

The underappreciated second-order effect is portfolio repricing. Grand Hyatt Scottsdale’s ramp plus W Nashville’s re-concepting create a path for incremental EBITDA that is not fully visible in near-term consensus, while the company’s emphasis on select dispositions suggests capital is being recycled away from lower-growth assets into higher-return uses. That combination can lift per-share value even if consolidated growth looks merely mid-single-digit, because the balance sheet already has enough flexibility to avoid forced funding decisions.

The key risk is that guidance is now more dependent on transient demand and less on event-driven upside; that is usually better for durability but worse for narrative-driven upside surprises. In other words, the market may be underestimating the downside if business transient rolls over in 2H, especially given the tougher comp setup and the fact that some of the current beat is being masked by one-time calendar effects and renovation noise in weaker assets.

Net/net, the stock likely deserves to trade on FFO multiple expansion if management can show April/May pacing holds and margins keep widening. But if the market keeps focusing on the muted event uplift, that creates an attractive entry point for patient capital because the company is effectively buying back optionality through portfolio optimization and share repurchases at a discount to intrinsic value.

Key Decisions for Investors

• Long XHR on any 1-2 day post-earnings weakness; target 3-6 months as the market digests raised EBITDA/FFO guidance and better margin visibility. Risk/reward is favorable if April/May pace holds and the stock rerates toward a higher AFFO multiple.
• Use a call spread in XHR (3-6 month tenor) rather than outright equity to express upside from Scottsdale/W Nashville stabilization; this captures upside from incremental EBITDA while limiting downside if 2H transient demand softens.
• Pair trade: long XHR / short MAR over the next quarter. XHR has more visible self-help and capital allocation upside, while MAR is more exposed to brand-level demand normalization and less direct operating leverage from asset-specific renovations.
• If XHR rallies 8-10% on the guide raise, trim into strength unless management confirms July-August booking pace is still tracking above prior-year levels; the main catalyst window is the next 60-90 days of pacing data, not the current quarter print.
• Watch for any announcement of selective dispositions or repurchase acceleration; if confirmed, add on dips because that would signal management sees the shares as the highest-return use of capital.